These results suggest that high SMAD1 expression can be used as a diagnostic marker for CRC and as a marker associated with poor prognosis and immunoinfiltration when SMAD1 begins to be low expressed in CRC. The gene discussed is SMAD1; the disease is colorectal carcinoma.